0001104659-21-137700.txt : 20211112 0001104659-21-137700.hdr.sgml : 20211112 20211112095606 ACCESSION NUMBER: 0001104659-21-137700 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 EFFECTIVENESS DATE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC CENTRAL INDEX KEY: 0001704132 IRS NUMBER: 821204449 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18415 FILM NUMBER: 211400774 BUSINESS ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001704132 XXXXXXXX 09-30-2021 09-30-2021 false Foresite Capital Management IV, LLC

900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939

13F HOLDINGS REPORT 028-18415 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 11-12-2021 0 12 679115 INFORMATION TABLE 2 infotable.xml Aclaris Therapeutics, Inc. COM 00461U105 61183 3399034 SH SOLE 3399034 0 0 Cue Health Inc. COM 229790100 11882 1006089 SH SOLE 1006089 0 0 Cymabay Therapeutics, Inc. COM 23257D103 6523 1787094 SH SOLE 1787094 0 0 Decibel Therapeutics, Inc. COM 24343R106 2295 297711 SH SOLE 297711 0 0 Kinnate Biopharma Inc. COM 49705R105 222641 9671643 SH SOLE 9671643 0 0 Kura Oncology, Inc. COM 50127T109 34650 1849947 SH SOLE 1849947 0 0 Lyell Immunopharma, Inc. COM 55083R104 196576 13282181 SH SOLE 13282181 0 0 Nurix Therapeutics, Inc. COM 67080M103 36126 1205798 SH SOLE 1205798 0 0 Olema Pharmaceuticals, Inc. COM 68062P106 9426 342030 SH SOLE 342030 0 0 Pharvaris N.V. COM N69605108 57834 3261926 SH SOLE 3261926 0 0 Quantum-Si Incorporated COM CL A 74765K105 37227 4463619 SH SOLE 4463619 0 0 Tempest Therapeutics, Inc. COM 87978U108 2752 190213 SH SOLE 190213 0 0